Plan B Litigation Puts Teva At Odds With Advocacy Group
This article was originally published in The Tan Sheet
Executive Summary
Teva Pharmaceutical Industries and the Center for Reproductive Rights are butting heads over the company’s right to OTC market exclusivity for Plan B One-Step. CRR says the firm cannot assert a right to exclusivity that was never granted.